GlassScriptPhysician profile
Abram R Mozes
NPI 1568418689
$10,329.79
in general payments reported to CMS, 2019-2025
40 companies · $1,174 in 2025
The $1,174 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,687 · 2020: $1,237 · 2021: $925 · 2022: $1,173 · 2023: $2,780 · 2024: $1,352 · 2025: $1,174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,056 · Travel and Lodging: $1,251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,056.00 |
| Travel and Lodging | $1,250.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,376.45 | 2021-2025 | Micra, Selectsecure, Linq II |
| Medical Device Business Services, INC. | $885.22 | 2019 | |
| Janssen Pharmaceuticals, INC | $712.76 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $585.55 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $584.44 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $518.37 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $482.31 | 2021-2025 | Verquvo, Capvaxive |
| Abbott Laboratories | $448.64 | 2020-2025 | Gallant, Jot Dx, Allure Quadra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $426.16 | 2019-2025 | Jardiance |
| Medtronic Vascular, INC. | $416.54 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $391.19 | 2019-2024 | |
| Cvrx, INC. | $344.85 | 2022-2024 | Barostim Neo System |
| Biotronik INC. | $301.82 | 2019-2021 | |
| Amarin Pharma, INC. | $234.07 | 2019-2021 | |
| Amgen INC. | $200.27 | 2020-2025 | Repatha, Repatha |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $189.15 | 2019-2024 | Lifevest |
| Boston Scientific Corporation | $184.21 | 2021-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Astrazeneca Pharmaceuticals LP | $154.86 | 2019-2025 | Wainua, Farxiga |
| Irhythm Technologies, INC. | $90.71 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Kiniksa Pharmaceuticals International, Plc | $82.85 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $74.17 | 2022-2023 | Assure Wcd |
| Philips North America LLC | $73.35 | 2024-2025 | Ambulatory Monitoring & Diagnostics Undivided, (Cm9) Amb Mon & Diag Und, (5091) Amb Mon & Diag Und |
| Daiichi Sankyo INC. | $71.24 | 2024 | Injectafer |
| Inspire Medical Systems, INC. | $59.90 | 2024-2025 | Inspire |
| Lundbeck LLC | $56.98 | 2019 | |
| Novo Nordisk INC | $43.35 | 2024-2025 | Ozempic |
| Arbor Pharmaceuticals, INC. | $39.16 | 2021 | |
| Esperion Therapeutics, INC. | $36.98 | 2020-2021 | |
| Abiomed | $36.81 | 2025 | |
| Chiesi USA, INC. | $34.57 | 2020-2023 | Kengreal, Cleviprex |
| Edwards Lifesciences Corporation | $29.99 | 2024 | Sapien 3 Ultra Resilia |
| Alnylam Pharmaceuticals INC. | $29.00 | 2024 | Amvuttra |
| Kiniksa Pharmaceuticals, LTD. | $23.02 | 2023 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $22.38 | 2024 | Uptravi, Opsumit |
| Atricure, INC. | $17.99 | 2024 | |
| Vivaquant INC, Dba Rhythm Express | $16.68 | 2025 | Rhythm Express |
| Cordis US Corp. | $16.01 | 2025 | Mynx Control Venous |
| Heartflow, INC. | $15.46 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $11.17 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abram Mozes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.